Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®.

Biotechnology

Pharmaceutical

Veloxis Pharmaceuticals

Mark Hensley

Matthew Dumont

Jonathan Doering

Brian Turner

Alastair McEwan

Eric Hedge

Tracy Sapp

Ed Sleeper

Daisuke Okajima

Tunde Otulana

Noel Barnard

Stacy Wheeler

Umang S. Shah

Ulf Meier-Kriesche

The executive team at Veloxis Pharmaceuticals has a history of experience in the finance and accounting industries. They have also been involved with companies such as Chiesi USA, Inc., Cornerstone Therapeutics Inc., and FPL Group, Inc. In addition, they have also received education from universities such as Florida Atlantic University and the University of North Texas.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Veloxis Pharmaceuticals

Leadership Team

Board of Directors